Compugen’s headquarters are Compugen Ltd., 26 Harokmim Street, Bldg. D, Holon, Israel, 5885849. The Company also has offices in South San Francisco, CA.
Compugen was incorporated in Israel in 1993.
Compugen completed its IPO on NASDAQ in August 2000 and listed its shares on the Tel Aviv Stock Exchange in January 2002.
Compugen’s shares are listed on the NASDAQ (Global Market) and the Tel Aviv Stock Exchange under the ticker symbol CGEN.
December 31
Compugen has never paid dividends to its shareholders and does not plan to pay dividends for the foreseeable future.
American Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn, NY 11219 United States (800) 937-5449 (call center is open Monday through Friday, 8 AM to 8 PM ET) www.astfinancial.com info@amstock.com
Kost Forer Gabbay & Kasierer (a member of Ernst & Young Global), serves as the independent registered public accounting firm of the Company.
These documents can be found in the Investor Relations section of Compugen’s website.
Upcoming events may be viewed on the Events page of the Investor Relations section of Compugen’s website.
Quarterly and annual reports and other investor materials are available in the Investor Relations section of Compugen’s website. Additionally, all SEC filings can also be accessed directly from the SEC website.
On Compugen’s website, www.cgen.com, please go to the Investor Relations section under “Analyst Coverage”.
Based on our analysis of Compugen’s income, assets, activities, and market capitalization, we do not believe that Compugen was a PFIC for the taxable year ended December 31, 2021. However, because the determination of whether Compugen is a PFIC is a fact intensive determination made on an annual basis and because the applicable law is subject to varying interpretation, we cannot provide any assurance regarding Compugen’s PFIC status for the past, current or any future taxable year.
On the Compugen website, under Investor Relations, please complete the “Information Request Form”, or write to ir@cgen.com.